Stock Scorecard
Stock Summary for West Pharmaceutical Services Inc (WST) - $311.66 as of 11/20/2024 8:54:07 PM EST
Total Score
13 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for WST
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for WST
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for WST
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 | |
Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for WST
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Safety Rating Criteria for WST (59 out of 90)
Stock Price Rating (Max of 10) | 10 |
Historical Stock Price Rating (Max of 10) | 10 |
Stock Price Trend (Max of 10) | 9 |
Book Value (Max of 10) | 8 |
Book Value to Price (Max of 10) | 0 |
Analyst Buy Ratings (Max of 5) | 5 |
Analyst Strong Buy Ratings (Max of 5) | 4 |
Dividend Yield Percentage (Max of 10) | 1 |
Operating Margin (Max of 10) | 5 |
Trading Volume (Max of 10) | 5 |
Price to Earnings (Max of 10) | 2 |
Latest News for for WST
Financial Details for WST
Company Overview |
|
---|---|
Ticker | WST |
Company Name | West Pharmaceutical Services Inc |
Country | USA |
Description | West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania. |
Sector Name | MANUFACTURING |
Industry Name | FABRICATED RUBBER PRODUCTS, NEC |
Most Recent Quarter | 9/30/2024 |
Next Earnings Date | 2/13/2025 |
Stock Price History |
|
Last Day Price | 311.66 |
Price 4 Years Ago | 280.75 |
Last Day Price Updated | 11/20/2024 8:54:07 PM EST |
Last Day Volume | 431,591 |
Average Daily Volume | 811,704 |
52-Week High | 412.94 |
52-Week Low | 264.65 |
Last Price to 52 Week Low | 17.76% |
Valuation Measures |
|
Trailing PE | 45.65 |
Industry PE | 34.76 |
Sector PE | 38.01 |
5-Year Average PE | 48.97 |
Free Cash Flow Ratio | 45.97 |
Industry Free Cash Flow Ratio | 29.68 |
Sector Free Cash Flow Ratio | 48.04 |
Current Ratio Most Recent Quarter | 3.00 |
Total Cash Per Share | 6.78 |
Book Value Per Share Most Recent Quarter | 37.96 |
Price to Book Ratio | 8.28 |
Industry Price to Book Ratio | 7.80 |
Sector Price to Book Ratio | 4.56 |
Price to Sales Ratio Twelve Trailing Months | 7.92 |
Industry Price to Sales Ratio Twelve Trailing Months | 5.98 |
Sector Price to Sales Ratio Twelve Trailing Months | 2.42 |
Analyst Buy Ratings | 5 |
Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
Total Shares Outstanding | 72,422,000 |
Market Capitalization | 22,571,040,520 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | 11/13/2024 |
Last Dividend Amount | 0.20 |
Current Dividend Amount | 0.21 |
Total Years Dividend Increasing | |
Trailing Annual Dividend Rate | 0.81 |
Trailing Annual Dividend Yield | 0.26% |
Forward Annual Dividend Rate | 0.86 |
Forward Annual Dividend Yield | 0.28% |
5-Year Dividend Payments Count | 20 |
3-Year Average Dividend Yield | 0.23% |
5-Year Average Dividend Yield | 0.26% |
1-Year Dividend Growth Rate Percentage | 5.48% |
3-Year Dividend Growth Rate Percentage | 5.64% |
5-Year Dividend Growth Rate Percentage | 6.00% |
All-Time Dividend Growth Rate Percentage | 7.13% |
Dividend Payout Ratio | 12.04% |
Income Statement |
|
Quarterly Earnings Growth YOY | -13.60% |
Annual Earnings Growth | 1.28% |
Reported EPS 12 Trailing Months | 6.73 |
Reported EPS Past Year | 4.93 |
Reported EPS Prior Year | 8.08 |
Net Income Twelve Trailing Months | 499,600,000 |
Net Income Past Year | 593,400,000 |
Net Income Prior Year | 585,900,000 |
Quarterly Revenue Growth YOY | -0.10% |
5-Year Revenue Growth | 11.19% |
Operating Margin Twelve Trailing Months | 0.22 |
Balance Sheet |
|
Total Cash Most Recent Quarter | 490,900,000 |
Total Cash Past Year | 853,900,000 |
Total Cash Prior Year | 894,300,000 |
Net Cash Position Most Recent Quarter | 288,300,000 |
Net Cash Position Past Year | 647,100,000 |
Long Term Debt Past Year | 206,800,000 |
Long Term Debt Prior Year | 208,900,000 |
Total Debt Most Recent Quarter | 202,600,000 |
Equity to Debt Ratio Past Year | 0.93 |
Equity to Debt Ratio Most Recent Quarter | 0.93 |
Total Stockholder Equity Past Year | 2,881,000,000 |
Total Stockholder Equity Prior Year | 2,684,900,000 |
Total Stockholder Equity Most Recent Quarter | 2,752,100,000 |
Free Cash Flow |
|
Free Cash Flow Twelve Trailing Months | 321,600,000 |
Free Cash Flow Per Share Twelve Trailing Months | 4.44 |
Free Cash Flow Past Year | 414,500,000 |
Free Cash Flow Prior Year | 439,400,000 |
Options |
|
Put/Call Ratio | 0.23 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | 8.43 |
MACD Signal | 6.29 |
20-Day Bollinger Lower Band | 280.12 |
20-Day Bollinger Middle Band | 306.86 |
20-Day Bollinger Upper Band | 333.60 |
Beta | 1.00 |
RSI | 66.37 |
50-Day SMA | 338.34 |
150-Day SMA | 331.65 |
200-Day SMA | 340.53 |
System |
|
Modified | 11/19/2024 4:29:43 PM EST |